Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-21-044710)

Filing Details

Accession Number:: 0001104659-21-044710
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-03-31 15:50:18
Reporting Period:: 2021-03-29

Accepted Time:: 2021-03-31 15:50:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1508381	Bionik Laboratories Corp.	BNKL	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1209225	Gerald Peter Malone	C/O Bionik Laboratories Corp. 483 Bay Street, N105 Toronto A6 M5G 2C9		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Acquisiton	2021-03-29	26,430	$0.00	26,430	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The reporting person acquired the shares of common stock in lieu of cash payment for an aggregate of $70,833.41 in accrued and unpaid fees relating to reporting person's services as a director of the Issuer.